MYELODYSPLASTIC

作品数：29被引量：41H指数：4
导出分析报告
相关领域：医药卫生更多>>
相关作者：郝玉书杨崇礼孟繁军陈子兴傅琤琤更多>>
相关机构：中国医学科学院北京协和医学院苏州大学青岛大学更多>>
相关期刊：《Chinese Journal of Integrative Medicine》《World Journal of Hematology》《World Journal of Gastroenterology》《Oncology and Translational Medicine》更多>>
相关基金：国家自然科学基金更多>>
-
在结果中检索

检索结果分析

结果分析中...
共 条 记 录，以下是1-10
全选清除导出
参考文献引证文献引用追踪
视图：
排序：
Co-existing squamous cell carcinoma and chronic myelomonocytic leukemia with ASXL1 and EZH2 gene mutations:A case report被引量：1
《World Journal of Clinical Cases》2023年第15期3643-3650,共8页Lai-Jun Deng Yang Dong Mi-Mi Li Chang-Gang Sun 
BACKGROUND Chronic myelomonocytic leukemia(CMML),a rare clonal hematopoietic stem cell disorder characterized by myelodysplastic syndrome and myeloproliferative neoplasms,has a generally poor prognosis,and easily prog...
关键词：Squamous cell carcinoma Chronic myelomonocytic leukemia Myeloproliferative neoplasms MYELODYSPLASTIC ASXL1 gene mutations EZH2 gene mutations Case report 
Corticosteroid-resistant Sweet’s syndrome as the first manifestation of myelodysplastic/myeloproliferative neoplasm-unclassifiable:a case report
《Emergency and Critical Care Medicine》2022年第4期233-238,共6页Lina Pan Jingru Zhang Peng Li Chuanli Zhao Shaolei Zang Min Ji Fei Lu Jingjing Ye Chunqing Zhang Chunyan Ji 
the Shandong Provincial Natural Science Foundation(ZR2020MH119,ZR2020MH118);Distinguished Taishan Scholars in Climbing Plan(tspd20210321);National Nature Science Foundation of China(81400118,81700143);the horizontal subject of Shandong University(6010120072).
A middle-aged man was diagnosed with myelodysplastic/myeloproliferative neoplasm-unclassifiable(MDS/MPN-U),with severe and extensive corticosteroid-resistant Sweet’s syndrome(SS)as the first manifestation,with eviden...
关键词：Case report Corticosteroid-resistant Intravenous immunoglobulin Myelodysplastic/myeloproliferative neoplasmunclassifiable Sweet’s syndrome 
Allo-HSCT for acute myeloid leukemia with myelodysplastic-related changes:a clinical analysis
《China Medical Abstracts(Internal Medicine)》2022年第1期55-56,共2页ZHANG Haixiao 
Objective To evaluate the outcomes and prognostic factors of adults with acute myeloid leukemia with myelodysplastic-related changes(AML-MRC)who received allogeneic hematopoietic stem cell transplantation(allo-HSCT).T...
关键词：ACUTE MYELOID LEUKEMIA 
骨髓增生异常综合征合并自身免疫性疾病的临床特征及预后分析被引量：1
《临床医学进展》2021年第4期1804-1812,共9页江东妮 孟繁军 
目的:探讨伴发自身免疫性疾病(AIDs)的骨髓增生异常综合征(MDS)患者的临床特征并分析其对疾病预后的影响。方法:回顾性分析206例初诊MDS患者的临床资料,依据有无合并AIDs分为两组,比较合并AIDs组与未合并组间患者的一般临床特征及预后...
关键词：骨髓增生异常综合征(Myelodysplastic Syndrom) 自身免疫性疾病(Autoimmune Diseases) 生存分析 PFS OS 
Decreased CD10-positive granulocytes for the differential diagnosis of myelodysplastic syndrome
《BIOCELL》2020年第4期607-611,共5页JIYU WANG HUIPING WANG YING PAN QIANSHAN TAO ZHIMIN ZHAI 
the National Natural Science Foundation of China(81670179);Research Fund Project of Anhui Medical University(No.2018xkj026);National Natural Science Foundation Incubation Project of the Second Hospital of Anhui Medical University(Grant No.2019GQFY11).
Myelodysplastic syndromes(MDS)are highly heterogeneous myeloid neoplasms,and a large number of patients are difficult to diagnose and classify by blood and bone marrow examination.As a surface marker of granulocyte,st...
关键词：MYELODYSPLASTIC SYNDROMES CD10 GRANULOCYTES Flow CYTOMETRY Differential diagnosis 
Acute myeloid leukemia with t(11;19)(q23;p13.1) in a patient with a gastrointestinal stromal tumor undergoing imatinib therapy:A case report
《World Journal of Clinical Cases》2020年第7期1251-1256,共6页Hong Jun Kim Sun Kyung Baek Chi Hoon Maeng Si-Young Kim Tae Sung Park Jae Joon Han 
BACKGROUND Acute myeloid leukemia(AML)harboring 11q23 translocations is classified as therapy-related AML in patients who have undergone prior treatment with cytotoxic agents.There have been only a few reports of AML ...
关键词：Acute MYELOID leukemia Gastrointestinal STROMAL tumor IMATINIB KMT2A MYELODYSPLASTIC syndrome Case report 
Relation of Blood Arsenic Concentration with Effect and Safety of Arsenic-Containing Qinghuang Powder (青黄散) in Patients with Myelodysplastic Syndrome被引量：9
《Chinese Journal of Integrative Medicine》2019年第7期497-501,共5页DENG Zhong-yang ZHU Shi-rong WANG Ming-jing FANG Su ZHAO Pan ZHU Qian-zhe WANG Hong-zhi GUO Xiao-qing XU Yong-gang YI Bo-wen SHANG Xiao-hong MA Rou HU Xiao-mei 
Supported by Beijing Municiple Science and Technology Commission(No.Z141100006014003);National Natural Science Foundation of China(No.81673821);Special Research Foundation of Central Level Public Scientific Research Institutes(No.ZZ10-016)
Objective: To investigate the relation of blood arsenic concentration (BAC) with clinical effect and safety of arsenic-containing Qinghuang Powder (青黄散,QHP) in patients with myelodysplastic syndrome (MDS). Methods:...
关键词：MYELODYSPLASTIC syndrome REALGAR ARSENIC Qinghuang Powder Chinese medicine 
Association of Gene Mutations with Response to Arsenic-Containing Compound Qinghuang Powder(复方青黄散)in Patients with Myelodysplastic Syndromes被引量：8
《Chinese Journal of Integrative Medicine》2019年第6期409-415,共7页ZHAO Pan LIANG Jun-bin DENG Zhong-yang WANG Ming-jing QIN Jia-yue CHEN Chong-jian HU Xiao-mei 
Supported by the Beijing Municiple Science and Technology Commission(No.Z141100006014003);the National Natural Science Foundation of China(No.81673821);the Special Research Foundation of Central Level Public Scientific Research Institutes(No.ZZ10-016)
Objective: To in vestigate the relati on ship betwee n gene mutations and resp onse to Compo und Qinghuang Powder (复方青黄散,CQHP) in patients with myelodysplastic syndrome (MDS). Methods: Forty-three MDS patients af...
关键词：MYELODYSPLASTIC SYNDROMES arsenic next-generation sequencing REALGAR 
Minimal residual disease-directed immunotherapy for high-risk myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation被引量：3
《Frontiers of Medicine》2019年第3期354-364,共11页Xiaodong Mo Xiaohui Zhang Lanping Xu Yu Wang Chenhua Yan Huan Chen Yuhong Chen Wei Han Fengrong Wang Jingzhi Wang Kaiyan Liu Xiaojun Huang 
Capital's Funds for Health Improvement and Research (No.2018-4-4089);the Key Program of the National Natural Science Foundation of China (No.81530046);Foundation for Innovative Research Groups of the National Natural Science Foundation of China (No.81621001);the Science and Technology Project of Guangdong Province of China (No.2016B030230003);the National Science and Technology Support Program (No.2014BAI09B13);the Project of Health Collaborative Innovation of Guangzhou city (No.201704020214).
The efficacy of minimal residual disease (MRD)-directed immunotherapy,including interferon-α (IFN-α) treatment and chemotherapy plus granulocyte colony-stimulating factor-primed donor leukocyte infusion (chemo-DLI),...
关键词：donor LEUKOCYTE INFUSION HEMATOPOIETIC stem cell transplantation INTERFERON-Α minimal residual disease MYELODYSPLASTIC syndrome 
Effect of Qinghuang Powder(青黄散) Combined with Bupi Yishen Decoction(补脾益肾方) in Treating Patients with Refractory Cytopenia with Multilineage Dysplasia through Regulating DNA Methylation被引量：12
《Chinese Journal of Integrative Medicine》2019年第5期354-359,共6页ZHOU Qing-bing YANG Xiao-hong WANG Hong-zhi WANG De-xiu XU Yong-gang HU Xiao-mei XU Feng-qin MA Rou 
Supported by the National Natural Science Foundation of China(No.81273931,No.81603490)
Objective: To explore the effect of Qinghuang Powder(QHP, 青黄散) combined with Bupi Yishen Decoction(BPYS, 补脾益肾方)on myelodysplastic syndromes(MDS) patients with refractory cytopenia with multilineage dysplasia(R...
关键词：Qinghuang Powder Bupi Yishen Decoction MYELODYSPLASTIC SYNDROMES DEMETHYLATION Chinese medicine 
全选清除导出
共3页<123>
检索报告 对象比较 聚类工具 使用帮助 返回顶部